Borregaard ASA

Research Borregaard ASA (BO4) on Bullrun: market cap EUR 1.44B, P/E 96.5, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 1.44B; P/E is 96.5; dividend yield is 3.1%.

Peer valuation comparison

Latest P/E is 96.53x versus a Basic Materials sector median of 17.36x (456.0% above).

Latest dividend yield is 3.05% versus a Basic Materials sector median of 2.19% (39.3% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024NOK 7.62BNOK 829.00Mn/an/a8.25NOK 82.00MNOK 2.04BNOK 5.04B
FY2023NOK 7.13BNOK 856.00Mn/an/a8.71NOK 469.00MNOK 2.02BNOK 4.86B
FY2022NOK 6.88BNOK 851.00Mn/an/a8.92NOK 234.00MNOK 1.37BNOK 4.45B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-07-26EUR 1.44B96.53.0%0.44

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.44 EUR, yield 3.1%.

YearDividends/share
FY20240.34 NOK
FY20230.3 NOK
FY20220.45 NOK

About Borregaard ASA

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry.

Related stock research

Other Basic Materials stocks

Frequently asked questions

What is Borregaard ASA's market cap?

Borregaard ASA's market capitalization is EUR 1.44B.

What is Borregaard ASA's P/E ratio?

Borregaard ASA's price-to-earnings (P/E) ratio is 96.5.

Does Borregaard ASA pay a dividend?

Borregaard ASA has a dividend yield of 3.1%.

What does Borregaard ASA do?

Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry.